Cholic acid is a primary bile acid that is insoluble in water (soluble in alcohol and acetic acid), it is a white crystalline substance. Cholic acid, along with chenodeoxycholic acid, is one of the two major bile acids produced by the liver, where it is synthesized from cholesterol. Cholic Acid used as an intermediate in pharmaceuticals, for instance, Sodium cholate is one of the choleretic drugs for the treatment of cholecystitis, bile deficiency, intestinal dyspepsia.
The global Cholic Acid market is estimated to be USD xxxx million in 2019 and is expected to reach USD xxxx million by 2026, with a CAGR of xxxx% during the forecast period.
Get FREE Sample of Cholic Acid Market Report at:
Key Players
Key players in the Cholic Acid market include Suzhou Tianlu Bio-Pharmaceutical, Tianjin NWS Biotechnology and Medicine, Zhongshan Belling Biotechnology, Shanghai Tauto Biotech, Bruschettini, Haihang Industry, Dr Falk Pharma, Shandong Green Bio-Pharmaceutical, Daewoong, Beijing Yunbang Biosiciences, Anhui Chem-Bright Bioengeneering, Shaanxi Top Pharm Chemical, DaxingAnLing Snow Lotus Herb Bio-Technology, and etc.
Market Dynamics
The growing application of Cholic Acid used for biochemical research and as pharmaceuticals intermediates is fueling the demand for Cholic Acid across the world. The numerous properties make the material an extremely important substance for medical end-users applied in many treatments processes. For instance, Cholic Acid has a steroid structure so that it can emulsify fat and facilitate cholesterol excretion. Further, as a major bile acid produced in the liver and usually conjugated with glycine or taurine, the growing prevalence of liver disease and peroxisomal disorders will soar demand for the medicine application, which in turn propel the market growth.
Purchase a copy of Cholic Acid report at:
Regional Analysis
North America is estimated to exhibit the highest market revenue due to the high prevalence of diabetes, obesity, non-alcoholic fatty liver disease, and other metabolic diseases, thus soaring the requirement of Cholic Acid medicine for treatment. Developing economies such as China and India pose a lucrative opportunity for growth under the local body’s significant investments in clinical research projects to lower the prevalence or risk of corresponding chronic acute hepatitis.
Region Analyzed Outlook
l North America (U.S., Canada, Mexico)
l Europe (Germany, France, Italy, Spain, U.K., Nordic Countries, Belgium, Russia, Rest of Europe
l Asia Pacific (China, India, Australia, Japan, South Korea, Australia and New Zealand, Rest of Asia Pacific)
l Latin America, Middle East & Africa (Brazil, Nigeria, Argentina, South Africa, GCC Countries.
l Others
Type Outlook
l Folding Ethanol Crystallization Method
l Folding Ethyl Acetate Separation Method
l Folding Animal Extraction
Application Outlook
l Organic Acid
l Emulsifier Application
l Medicine
Ask for a discount at:
Years considered for the study
• Base Year: 2018
• Estimated Year: 2019
• Forecast Period: 2019 to 2026
Target Audience
• Cholic Acid Biotechnology and Medicine manufacturers
• Raw material suppliers of Cholic Acid materials
• Downstream industry and end-users
• Bioengineering, Biosciences, Bio-Pharmaceuticals company
• Chemical materials industry associations and clinical laboratory
• Product managers, Cholic Acid industry administrator, C-level executives of the industries
• Market Research and consulting firms
Contact:
Global Market Monitor
One Pierrepont Plaza, 300 Cadman Plaza W, Brooklyn,
NY 11201, USA
Phone: + 1 (347) 467 7721
Email: info@globalmarketmonitor.com
Web Site: https://www.globalmarketmonitor.com
We provide more professional and intelligent market reports to complement your business decisions.
Chinese